Abbvie Partnering 2009-2014
Published: Aug 2014 | Publisher: Current Partnering | Pages: 100SUMMARY
This report provides all the information you require to better understand Abbvie and its partnering interests and activities over the past seven years
TABLE OF CONTENTS
Executive Summary
Chapter 1 – Introduction
Chapter 2 – Biopharma top 50 and dealmaking activity
2.1 Biopharma partnering activity
2.2 Biopharma M&A activity
Chapter 3 – Top bigpharma deals by value
3.1 Bigpharma M&A
3.2 Bigpharma partnering
Chapter 4 – Submitting Opportunities to Prospective Partners
4.1 How to submit an opportunity
4.2 Opportunity submission template
4.3 Sending emails
4.4 Face to face at partnering events
4.5 Online submission forms
Chapter 5 – Forthcoming partnering events
Chapter 6 – Company Profile
6.1 How to use company profiles
6.2 Field definitions
6.3 Company profile
Partnering deals directory (2009-present) - by industry sector
Bigpharma
Pharmaceutical
Biotech
Diagnostic
Drug delivery
Government
Medical device
Consumer health
Specialty pharma
Generic pharma
Agricultural
Animal health
Academic
Non-profit
Research tools
Services
Partnering deals directory (2009-present) - By deal type
Asset purchase
Co-Development
Co-Market
Co-Promotion
Collaborative R&D
Contract service
Development
Distribution
Evaluation
Joint venture
Licensing
Manufacture
Marketing
Promotion
Research
Royalty financing
Supply
Partnering deals directory (2009-present) – M&A
Partnering deals directory (2009-present) - By stage of development
Discovery
Preclinical
Phase I
Phase II
Phase III
Regulatory
Marketed
Formulation
Partnering deals directory (2009-present) - By therapy area
Hospital care
Cardiovascular
Central nervous system
Cosmetic
Dental
Dermatology
Gastrointestinal
Genetic disorders
Genitourinary
Hemotology
Immunology
Infectives
Inflammatory
Metabolic
Musculoskeletal
Oncology
Ophthalmics
Respiratory
Sensory organ
About Wildwood Ventures
Current Partnering
Current Agreements
Recent titles from CurrentPartnering
Order Form – Reports
Order Form – Partnering Agreements
Company Profiles
TABLE OF FIGURES
Figure 1: Bigpharma partnering activity – top 50 by pharma sales
Figure 2: Bigpharma M&A activity – top 50 by pharma sales
Figure 3: Leading M&A deals involving bigpharma by value, 2009-2014
Figure 4: Leading partnering deals by value, 2009-2014
Figure 5: Typical partnering opportunity submission template
Figure 6: Company profile template and definitions used in report
Figure 7: Dealmaking frequency 2009-2014
Figure 8: Current partner companies (2009-present)
Figure 9: Partnering deals by type (2009-present)
Figure 10: Recent deals (2009-present) by industry sector
Figure 11: Recent deals (2009-present) by deal type
Figure 12: Recent deals (2009-present) by stage of development
Figure 13: Recent deals (2009-present) by therapy area
Chapter 1 – Introduction
Chapter 2 – Biopharma top 50 and dealmaking activity
2.1 Biopharma partnering activity
2.2 Biopharma M&A activity
Chapter 3 – Top bigpharma deals by value
3.1 Bigpharma M&A
3.2 Bigpharma partnering
Chapter 4 – Submitting Opportunities to Prospective Partners
4.1 How to submit an opportunity
4.2 Opportunity submission template
4.3 Sending emails
4.4 Face to face at partnering events
4.5 Online submission forms
Chapter 5 – Forthcoming partnering events
Chapter 6 – Company Profile
6.1 How to use company profiles
6.2 Field definitions
6.3 Company profile
Partnering deals directory (2009-present) - by industry sector
Bigpharma
Pharmaceutical
Biotech
Diagnostic
Drug delivery
Government
Medical device
Consumer health
Specialty pharma
Generic pharma
Agricultural
Animal health
Academic
Non-profit
Research tools
Services
Partnering deals directory (2009-present) - By deal type
Asset purchase
Co-Development
Co-Market
Co-Promotion
Collaborative R&D
Contract service
Development
Distribution
Evaluation
Joint venture
Licensing
Manufacture
Marketing
Promotion
Research
Royalty financing
Supply
Partnering deals directory (2009-present) – M&A
Partnering deals directory (2009-present) - By stage of development
Discovery
Preclinical
Phase I
Phase II
Phase III
Regulatory
Marketed
Formulation
Partnering deals directory (2009-present) - By therapy area
Hospital care
Cardiovascular
Central nervous system
Cosmetic
Dental
Dermatology
Gastrointestinal
Genetic disorders
Genitourinary
Hemotology
Immunology
Infectives
Inflammatory
Metabolic
Musculoskeletal
Oncology
Ophthalmics
Respiratory
Sensory organ
About Wildwood Ventures
Current Partnering
Current Agreements
Recent titles from CurrentPartnering
Order Form – Reports
Order Form – Partnering Agreements
Company Profiles
TABLE OF FIGURES
Figure 1: Bigpharma partnering activity – top 50 by pharma sales
Figure 2: Bigpharma M&A activity – top 50 by pharma sales
Figure 3: Leading M&A deals involving bigpharma by value, 2009-2014
Figure 4: Leading partnering deals by value, 2009-2014
Figure 5: Typical partnering opportunity submission template
Figure 6: Company profile template and definitions used in report
Figure 7: Dealmaking frequency 2009-2014
Figure 8: Current partner companies (2009-present)
Figure 9: Partnering deals by type (2009-present)
Figure 10: Recent deals (2009-present) by industry sector
Figure 11: Recent deals (2009-present) by deal type
Figure 12: Recent deals (2009-present) by stage of development
Figure 13: Recent deals (2009-present) by therapy area
$995
My Basket
 | Co-development Terms & Agreements in Pharma, Biotech and Diagnostics | $2,995 |
| Abbvie Partnering 2009-2014 | $995 |
| TOTAL | $3,990 | |
| Empty Cart | ||
| ||
Need Help?
Unsure which report to purchase or have a query regarding a report, please contact us and we'll be glad to help.
Contact our Report Store Team
Email us or call
+44 (0)1904 435190 Europe
+1 (813) 971.8273 US
- Most Viewed